Hypoxia‐responsive AIEgens for precise disease theranostics
Luminescence · 2024-01 · 39 (1)
DOI: 10.1002/bio.4659 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Luminescence, online erschienen am 16.01.2024. Verfasst von Dongfang Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bionic Engineering, Ministry of Education, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Precision Medicine, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: NSFC, Science and Technology Program of Tianjin, China, Fundamental Research Funds for the Central Universities, Nankai University.
Abstract (Originalsprache)
Specific biomarker‐activatable probes have revolutionized theranostics, being beneficial for precision medicine. Hypoxia is a critical pathological characteristic prevalent in numerous major diseases such as cancers, cardiovascular disorders, inflammatory diseases, and acute ischemia. Aggregation‐induced emission luminogens (AIEgens) have emerged as a promising tool to tackle the biomedical issues. Of particular significance are the hypoxia‐responsive AIEgens, representing a kind of crucial probe capable of delicately sensing and responding to the hypoxic microenvironment, thereby enhancing the precision of disease diagnosis and treatment. In this review, we summarize the recent advances of hypoxia‐responsive AIEgens for varied biomedical applications. The hypoxia‐responsive structures based on AIEgens, such as azobenzene, nitrobenzene, and N‐oxide are presented, which are in response to the reduction property to bring about significant alternations in response spectra and/or fluorescence intensity. The bioapplications including imaging and therapy of tumor and ischemia diseases are discussed. Moreover, the review sheds light on the future challenges and prospects in this field. This review aims to provide comprehensive guidance and understanding into the development of activatable bioprobes, especially the hypoxia‐responsive AIEgens for improving the diagnosis and therapy outcome of related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Bionic Engineering, Ministry of Education, Jilin University, Changchun, China.
- School of Chemistry and Life Science, Changchun University of Technology, Changchun, China.
- State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of Education, Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin, China.
ORCID-Profile: Ji Qi
Förderung
- NSFC
- Science and Technology Program of Tianjin, China
- Fundamental Research Funds for the Central Universities, Nankai University
- National Natural Science Foundation of China
Zitieren
APA
Liu, D., Liang, M., Fan, A., Bing, W., & Qi, J. (2024). Hypoxia‐responsive AIEgens for precise disease theranostics. Luminescence, 39(1). https://doi.org/10.1002/bio.4659
Vancouver
Liu D, Liang M, Fan A, Bing W, Qi J. Hypoxia‐responsive AIEgens for precise disease theranostics. Luminescence. 2024;39(1). doi:10.1002/bio.4659
BibTeX
@article{Liu2024,
author = {Liu, Dongfang and Liang, Mengyun and Fan, Aohua and Bing, Wei and Qi, Ji},
title = {Hypoxia‐responsive AIEgens for precise disease theranostics},
journal = {Luminescence},
year = {2024},
volume = {39},
number = {1},
doi = {10.1002/bio.4659}
}
EUVIMED